The firm believes that its definitive monomicrobial test, which usually eliminates the need for additional validation testing, may give it an edge over competitors.
The firm reported preliminary revenues of $246,000 for 2016, and said that after receiving FDA clearance, it expects a lift in sales of its ID/AST blood-based infection test.
The PhenoTest BC Kit identifies organisms that cause bloodstream infections and provides information about antibiotic sensitivity.
Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco, CA, Day 3.
The test is based on a biomarker signature that consists of a core set of 31 genes associated with endotoxin tolerance in sepsis patients.
Despite the array of tests available, some lab directors are still seeking broader functionalities and capabilities from the systems they purchase.
The US District Court for the District of Arizona has granted Accelerate Dx's motion to dismiss a class-action lawsuit filed against it last year.